FdaApplication
ANDA 210227
Identifiers
- fda_app_no: ANDA210227
Properties
| Property | Value |
|---|---|
| applicant_name | XIROMED LLC |
| application_type | ANDA |
| approval_date | 2018-10-12 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MEDROXYPROGESTERONE ACETATE | MEDROXYPROGESTERONE ACETATE | 150MG/ML | INJECTABLE;INJECTION |
1 product